Avacta Group Share News (AVCT)

Avacta Launches Pancreatitis Test For Dogs

LONDON (Alliance News) - Avacta Group PLC said Monday it has completed development and validation of a new test for pancreatitis in dogs. The provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare said the new test uses an algorithm to combine the

Avacta Notes Positive Development Progress For Affirmers

LONDON (Alliance News) - Avacta Group Thursday said it has achieved certain technical milestones towards commercial progress regarding its commercialisation of Affirmer reagents for life sciences research. Affimer reagents are engineered alternatives to antibodies designed to address many o

Thursday broker round-up UPDATE

Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

DIRECTOR DEALINGS: Avacta Non-Executive Exercises 3.5M Share Options

LONDON (Alliance News) - Avacta Group PLC Monday said Non-Executive Chairman Trevor Nicholls exercised options over 3.5 million shares at an exercise price of 55 pence per share, making the transaction worth GBP1.9 million. Nicholls now holds 3.5 million shares, which represents 0.1% of the

Avacta Collaborating With Liverpool University On Biomarker Research

LONDON (Alliance News) - Avacta Group PLC said Monday that it had commenced a collaboration with Liverpool University, working on a project to develop efficient methods of identifying proteins as potential biomarkers. A biomarker is a characteristic that can be measured to indicate a biolog

Avacta Launches New Website To Commercialise Reagents

LONDON (Alliance News) - Avacta Group PLC said Tuesday that that it had launched a new web site to commercialise its Affimer reagents, which are engineered alternatives to antibodies. The biotechnology company said the new website marks the start of the commercialisation of the Affimers. It

Avacta Group Says First-Half Trading In Line With Market Hopes

LONDON (Alliance News) - Avacta Group PLC Friday said trading for the first half of its financial year was in line with market expectations, driven by good progress at its analytical unit. In a statement ahead of its annual general meeting, the provider of proprietary diagnostic tools, cons

UK MORNING BRIEFING: Shares Open Higher On Interest Rate Assurance

LONDON (Alliance News) - UK shares have opened higher Friday, as Bank of England Governor Mark Carney backed off of forward guidance and said there is "no immediate need" to raise interest rates.

Royal Mail has reported a 2% increase in like-for-like revenues for th

Avacta Group Launches New Canine Lymphoma Blood Test In UK

Avacta Widens Losses As Revenues Fall On Slow Sales